Looking back, Otto remembers struggling to breathe when he was as young as four. Exertion would make him cough, and the coughing fits would go on and on. Growing up in a family of eight children in a village in northern Uganda, he would try to run and play with other kids. But usually he… Read More
Vaxent chief scientific officer James B. Dale, who also serves as a professor of medicine and chief of the division of infectious diseases at the University of Tennessee Health Science Center, invented the vaccine based on more than 25 years of laboratory research.
Vaxent chief scientific officer James B. Dale, who also serves as a professor of medicine and chief of the division of infectious diseases at the University of Tennessee Health Science Center, invented StreptAnova based on more than 25 years of laboratory research.
The vaccine was developed by Dr. James Dale at the University of Tennessee Health Science Center and is being commercialized by PREVENT and Vaxent. The Phase I trial was announced in August.
Dr. James B. Dale developed StreptAnova at the University of Tennessee Health Sciences Center. . . StreptAnova will soon undergo a Phase 1 clinical trial in Halifax, Nova Scotia, to test its effectiveness and whether it is safe for humans.
